Polaris News

Quantum Cloud Growth and the Future of Computing
Just a few years ago, truly viable and useful quantum computing was the stuff of legends and campfire tales among computer scientists, but development in the last year has led to an explosion of quantum resources available to companies in the cloud. The evolution of the quantum machine has been accelerated by the development of…
Read more
Fujitsu Highlights POLARISqb as a Tech Innovator Driving Digital Transformation

Last year Polarisqb  began our journey to revolutionize the world of drug discovery by using the most advanced computers on the planet to perform in silico protein targeting at speeds never before thought possible. One of our most important partners in this new venture was Fujitsu, who had developed the most sophisticated Digital Annealing Computer on the planet.

PolarisQB was featured as an innovative customer in Fujitsu's eBook on driving digital transformation.

Using this machine that can reach near quantum speeds we designed our Tachyon platform that is able to perform complex simulations of molecular and chemical reactions that provide crucial information to scientists and researchers who are working to develop treatments and cures for diseases that affect billions of people around the globe.

Fujitsu has recognized this work in an eBook titled Driving Digital Transformation with our Customers along with five other companies that are utilizing high powered computers to drive innovation in the fields of logistics, finance, fashion, food supply, and aerospace. Read more about our work and the other customers who made the list below.

Fujitsu: Driving Digital Transformation With Our Customers

Auransa and POLARISqb Enter Research Collaboration to find Treatments for Neglected Women’s Diseases
PALO ALTO, Calif. and DURHAM, N.C., June 04, 2021 /PRNewswire/ -- Auransa, Inc., an artificial intelligence (AI) company developing precision medicines in areas of unmet medical needs, and Polaris Quantum Biotech (POLARISqb), a quantum drug design company, announced a research collaboration addressing therapeutics for neglected diseases disproportionately affecting women.  The partnership seeks to discover treatments that may tackle…
Read more